Results 171 to 180 of about 6,491 (191)

Palivizumab and RSVIG

Inpharma Weekly, 1998
openaire   +2 more sources

Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants

Journal of Paediatrics and Child Health, 2002
Catherine Byrnes, Keith Grimwood
exaly  

Palivizumab

2006
openaire   +1 more source

Treatment of respiratory syncytial virus with palivizumab: a systematic review

World Journal of Pediatrics, 2010
Joan Robinson
exaly  

Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis

European Journal of Clinical Microbiology and Infectious Diseases, 2017
Bernhard Resch, B Urlesberger
exaly  

Palivizumab

2013
openaire   +1 more source

Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis

Allergologia Et Immunopathologia, 2015
Manuel Sanchez-Solis, Luis Garcia-Marcos, Silvia Gartner   +2 more
exaly  

Recurrent Wheezing in Childhood and Palivizumab

American Journal of Respiratory and Critical Care Medicine, 2017
Heather E. Hoch, Joseph M. Collaco
openaire   +2 more sources

Adherence and outcomes: a systematic review of palivizumab utilization

Expert Review of Respiratory Medicine, 2018
Krista L Lanctôt, Abby Li, Bosco Paes
exaly  

PALIVIZUMAB (SYNAGIS)

American Journal of Nursing, 1999
openaire   +1 more source